Effects of DPH on fetal development were studied using a dose which produced 65% cleft palate in the CD-1 strain. Generalized developmental retardation and diminution of fatal muscular movements occurred at the early fetal stage. Intermediate stages of palate closure persisted to term, indicating interference with palatine shelf rotation.
Get full access to this article
View all access options for this article.
References
1.
Smith, D.W.: Teratogenicity of Anticonvulsive Medications, Am J Dis Child131: 1337-1339, 1977.
Meadow, S.R.: Congenital Abnormalities and Anticonvulsant Drugs, Proc Roy Soc Med63:48-49, 1970.
4.
Speidel, B.D., and Meadow, S.R.: Maternal Epilepsy and Abnormalities of the Fetus and Newborn. Lancet2:839-843, 1972.
5.
Starreveld-Zimmerman, A.A.E.; Vander Kolk, W.J.; Elshore, J.; and Meinardi, H.: Teratogenicity of Antiepileptic Drugs, Clin Neurol Neurosurg77:81-95, 1974.
6.
Hanson, J.W. , and Smith, D.W.: The Fetal Hydantoin Syndrome, J Pediatr87: 285-290, 1975.
7.
Pashayan, H. ; Pruzansky, D.; and Pruzansky, S.: Are Anticonvulsants Teratogenic ? Lancet2:702-703, 1971.
8.
Gibson, J.E. , and Becker, B.A.: Teratogenic Effects of Diphenylhydantoin in Swiss-Webster and A/J Mice, Proc Soc Exp Biol Med128:905-909, 1968.
9.
Fritz, H.: The Effect of Cortisone on the Teratogenic Action of Acetylsalicylic Acid and Diphenylhydantoin in the Mouse, Separatum Experientia32:721-722, 1976.
10.
Harbison, R.D. , and Becker, B.A.: Diphenylhydantoin Teratogenicity in Rats , Toxicol Appl Pharmacol22:193-200, 1972.
11.
Mirkin, B.L. : Diphenylhydantoin: Placental Transport, Fetal Localization, Neonatal Metabolism, and Possible Teratogenic Effects, J Pediatr78:329-337, 1971.
12.
Gabler, W.L. , and Hubbard, G.L.: The Distribution of 5, 5-Diphenylhydantoin (DPH) and its Metabolites in Maternal and Fetal Rhesus Monkey Tissues, Arch Int Pharmacodyn200:222-230, 1972.
13.
Stevens, M.W. , and Harbison, R.D.: Placental Transfer of Diphenylhydantoin: Effects of Species, Gestational Age, and Route of Administration, Teratology9: 317-326, 1974.
14.
Waddell, W.J. , and Mirkin, B.L.: Distribution and Metabolism of Diphenylhydantoin-14C in Fetal and Maternal Tissues of the Pregnant Mouse, Biochem Pharmacol21 :547-552,1972.
15.
Harbison, R.D. , and Becker, B.A.: Comparative Embryotoxicity of Diphenylhydantoin and Some of its Metabolites in Mice, Teratology10:237-242, 1974.
16.
Bogoch, S., and Dreyfus, J. (eds): The Broad Range of Use of Diphenylhydantoin, New York: The Dreyfus Medical Foundation, Vol I, 1970.
17.
Bogoch, S., and Dreyfus, J. (eds): A Supplement to the Broad Range of Use of Diphenylhydantoin , New York: The Dreyfus Medical Foundation, Vol II, 1975.
18.
Schardein, J.L.; Dresner, A.J.; Hentz, D.L.; Petrere, J.A.; Fitz-Gerald, J.E.; and Kurtz, S.M.: The Modifying Effect of Folinic Acid on Diphenylhydantoin-Induced Teratogenicity in Mice, Toxicol Appl Pharmacol24:150-158, 1973.
19.
Walker, B.E. , and Quarles, J.: Effects of Anti-inflammatory Steroids on Mouse Embryonic Movements During Palatal Development, J Dent Res54:1200-1206, 1975.
20.
Walker, B.E. , and Patterson, A.: Induction of Cleft Palate in Mice by Tranquilizers and Barbiturates, Teratology10: 159-163, 1974.
21.
Walker, B.E. : Correlation of Embryonic Movement with Palate Closure in Mice, Teratology2:191-198, 1969.
22.
Walker, B.E. , and Fraser, F.C.: Closure of Secondary Palate in Three Strains of Mice, J Embryol Exp Morph4:176-189, 1956.
23.
Walker, B.E. : Effects on Palate Development of Mechanical Interference with the Fetal Environment, Science130:981, 1959.
24.
Walker, B.E. , and Quarles, J.: Palate Development in Mouse Embryos After Tongue Removal, Archs Oral Biol21 :405-412, 1976.
25.
Walker, B.E. , and Patterson, A.: Palate Development After Tongue Removal in Cortisone-treated Mice, Teratology17: 51-56, 1978.
26.
Lessard, J.L. ; Wee, E.L.; and Zimmerman , E.F.: Presence of Contractile Proteins in Mouse Fetal Palate Prior to Shelf Elevation, Teratology9:113-125, 1974.
27.
Walker, B.E. , and Fraser, F.C.: The Embryology of Cortisone-induced Cleft Palate, J Embryol Exp Morph5:201-209, 1957.
28.
Walker, B.E. , and Crain, B., JR.: Effects of Hypervitaminosis A on Palate Development in Two Strains of Mice, Amer J Anat107: 49-58, 1960.
29.
Walker, B.E. , and Crain B., JR.: Abnormal Palate Morphogenesis in Mouse Embryos Induced by Riboflavin Deficiency, Proc Soc Exp Biol Med107:404-406, 1961.
30.
Callas, G., and Walker, B.E.: Palate Morphogenesis in Mouse Embryos After X-irradiation, Anat Rec145:61-71, 1963.
31.
Walker, B.E. : Cleft Palate Production in Mice With a Therapeutic-equivalent Dose of Triamcinolone, Science149:862-863, 1965.
32.
Goldstein, A. : Biostatistics, An Introductory Text, New York: The Macmillan Company, 1964, p. 144.
33.
Harbison, R.D. , and Becker, B.A.: Relation of Dosage and Time of Administration of Diphenylhydantoin to its Teratogenic Effect in Mice, Teratology2 :305-312,1969.
34.
Miller, R.P., and Becker, B.A.: Teratogenicity of Oral Diazepam and Diphenylhydantoin in Mice, Toxicol Appl Pharmacol32:53-61, 1975.
35.
Anderson, R.J. , and Raines, A.: Suppression of Cerebellar Evoked Potentials by a Peripheral Action of Diphenylhydantoin, Arch Int Pharmacodyn218:144-155. 1975.
36.
Origuchi, Y.; Nonaka, I.; Ueno, T.; and Usuku, G.: Ultrastructural Changes in the Cerebellum of Young Rats Having Received Diphenylhydantoin During the Embryonal Stage, Kumamoto Med J28:84-93, 1975.
37.
Anderson, R.J. , and Raines, A.: Suppression by Diphenylhydantoin of Afferent Discharges Arising in Muscle Spindles of the Triceps Surae of the Cat, J Pharmacol Exp Ther191 :290-299, 1974.
38.
Millichap, J.G., and Boldrey, E.E.: Studies in Hyperkinetic Behavior II. Laboratory and Clinical Evaluations of Drug Treatments. Neurology17:467-471, 519, 1967.
39.
Martz F.; Failinger,C. IIII; and Blake, D.A. : Phenyltoin Teratogenesis: Correlation Between Embryopathic Effect and Covalent Binding of Putative Arene Oxide Metabolite in Gestational Tissue, J Pharm Exp Ther203:231-239, 1977.
40.
Gillette, J.R. ; Menard, R.H.; and Stripp, B.: Active Products of Fetal Drug Metabolism , Clin Pharmacol Ther14 :680-692, 1973.
